TRLV· Health Care› Drug Manufacturers - Specialty & Generic

Trulieve Cannabis Corp. Subordinate Voting Shares

Stage 2 · Advancing · week 11

As of Oct 22, 2026, Trulieve Cannabis Corp. Subordinate Voting Shares is in Stage 2, the uptrend phase, now in week 11 (since Aug 12, 2026). It closed at $10.92, 16.0% below its 52-week high and above its 200-day average, which is rising.

Trulieve Cannabis Corp. operates as a cannabis retailer in the United States. More about the company

$10.92

-1.71% today

$2.1B · Mid cap

Market Neutral — Building

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #1 of 26 in Drug Manufacturers - Specialty & Generic · #1 of 272 in Health Care

Is TRLV early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S2 22w

S4 24w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S4 2w → S1 6w → S2 5w → S3 6w → S2 22w → S3 12w → S2 11w → S3 1w → S4 24w → S1 9w → S4 3w → S1 2w → S2 11w → S3 8w → S2 8w → S3 4w → S4 4w → S1 3w → S2 9w → S3 2w → S2 10w current

Total tracked: 164 weeks across 21 stage runs.

TRLV among Drug Manufacturers - Specialty & Generic16th of 84 by relative strength

All 84 →

Stocks in Drug Manufacturers - Specialty & Generic ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	CPIXCumberland Pharmaceuticals Inc.	Stage 2 · wk 23	98	+6.8%
2	ETONEton Pharmaceuticals, Inc.	Stage 2 · wk 30	97	−10.1%
3	ANIKAnika Therapeutics Inc.	Stage 2 · wk 15	96	+3.5%
4	IRWDIronwood Pharmaceuticals, Inc. Class A	Stage 3 · wk 3	96	−16.4%
5	TEVATeva Pharmaceutical Industries Limited	Stage 2 · wk 9	95	+3.1%
6	AMRXAmneal Pharmaceuticals, Inc. Class A	Stage 2 · wk 19	95	+5.9%
7	KNSAKiniksa Pharmaceuticals International, plc Class A	Stage 2 · wk 73	95	+6.2%
8	AMLXAmylyx Pharmaceuticals, Inc.	Stage 2 · wk 15	93	−6.6%
…16	TRLVTrulieve Cannabis Corp. Subordinate Voting Shares	Stage 2 · wk 11	83	−12.9%

vs 52W High

-16.0%

$4.76 lo$13.00 hi

16.0% below 52W high, deeper pullback

How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.

Stage Maturity

Week 11

1w13w26w

Week 11, early Stage 2

How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.

vs 200 DMA

24.6%

200 DMA: $8.76 · rising

Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.

Rel Volume

0.64x

vs 50-day avg

Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-12.9%

+30.6%

+43.4%

YTD

+25.5%

+42.2%

Scan Membership

Breakout Watch

Latest: 2024-09-03

5 appearances in last 60 days. First seen: 2019-12-16.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S2

Wk 11 · Vol 0.64x

2026-10-21S2

Wk 10 · Vol 0.79x

2026-10-20S2

Wk 10 · Vol 0.63x

2026-10-19S2

Wk 10 · Vol 0.47x

2026-10-16S2

Wk 10 · Vol 0.49x

2026-10-15S2

Wk 10 · Vol 0.76x

2026-10-14S2

Wk 9 · Vol 0.94x

2026-10-13S2

Wk 9 · Vol 0.49x

2026-10-12S2

Wk 9 · Vol 0.55x

2026-10-09S2

Wk 9 · Vol 0.64x

2026-10-08S2

Wk 9 · Vol 0.82x

2026-10-07S2

Wk 8 · Vol 1.11x

Moving averages & range

50 DMA

$11.10

200 DMA

$8.76

52W High

$13.00

52W Low

$4.76

5D Low

$10.01

Resistance levels (recent highs)

20d High

$12.41

60d High

$12.54

120d High

$13.00

250d High

$13.00

Next resistance

+13.6%

to 20d High

ROE

-47.7%

Profit margin -41.6%

Dividend Yield

0.00%

P/B 2.7

Trulieve Cannabis Corp. Subordinate Voting Shares: quick answers

What stage is Trulieve Cannabis Corp. Subordinate Voting Shares in?

As of Oct 22, 2026, Trulieve Cannabis Corp. Subordinate Voting Shares (TRLV) is in Stage 2, the uptrend phase. It entered Stage 2 on Aug 12, 2026 and is in week 11. What the four stages mean

Is Trulieve Cannabis Corp. Subordinate Voting Shares in an uptrend?

Yes. Trulieve Cannabis Corp. Subordinate Voting Shares is in a Stage 2 uptrend. It trades 24.6% above its 200-day average, which is rising.

How far is Trulieve Cannabis Corp. Subordinate Voting Shares from its 52-week high?

Trulieve Cannabis Corp. Subordinate Voting Shares closed at $10.92 on Oct 22, 2026, 16.0% below its 52-week high of $13.00. Its 52-week low is $4.76.

How has Trulieve Cannabis Corp. Subordinate Voting Shares performed over the past year?

As of Oct 22, 2026, Trulieve Cannabis Corp. Subordinate Voting Shares is up 42.2% over the past year and up 25.5% so far in 2026.

Which sector and industry is Trulieve Cannabis Corp. Subordinate Voting Shares in?

Trulieve Cannabis Corp. Subordinate Voting Shares is in the Drug Manufacturers - Specialty & Generic industry, part of the Health Care sector.

About this companyHealth Care· Drug Manufacturers - Specialty & Generic

Trulieve Cannabis Corp. operates as a cannabis retailer in the United States. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery. It sells flowers, edibles, vapes, oral, topical, concentrates, and accessories under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, and Roll One brands. The company operates dispensaries in Florida, Arizona, Georgia, Ohio, Maryland, West Virginia, Connecticut, and Pennsylvania. It operates cultivation and processing facilities in Arizona, Colorado, Florida, Georgia, Maryland, Pennsylvania, and West Virginia. The company also offers medical cannabis dispensary in North Miami Beach, Florida. Trulieve Cannabis Corp. was formerly known as Schyan Exploration Inc./Exploration Schyan Inc. and changed its name to Trulieve Cannabis Corp. in September 2018. Trulieve Cannabis Corp. was incorporated in 1940 and is headquartered in Tallahassee, Florida.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.